Regeneron Pharmaceuticals shares owned by Tower Bridge Advisors
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Tower Bridge Advisors
from 13F filings
Historical chart of Tower Bridge Advisors investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Tower Bridge Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Tower Bridge Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $542k | 617 | 878.29 |
| 2023-09-30 | $508k | 617 | 822.96 |
| 2023-06-30 | $443k | 617 | 718.54 |
| 2023-03-31 | $425k | 517 | 821.67 |
| 2022-12-31 | $229k | 317 | 721.49 |
| 2022-09-30 | $218k | 317 | 688.87 |
| 2022-03-31 | $221k | 317 | 698.42 |
| 2021-12-31 | $200k | 317 | 631.52 |
More positions owned by Tower Bridge Advisors
Visa Common (V)
View all positions for Tower Bridge Advisors